Diseases of the central nervous system

Central nervous system disorders
Neurological disorders

Nature

Disorders of the nervous system may involve: (1) Vascular disorders, such as stroke, transient ischemic attack (TIA), subarachnoid hemorrhage, subdural hemorrhage and hematoma, and extradural hemorrhage.(2) Infections, such as meningitis, encephalitis, polio, and epidural abscess.

Background

The global significance of central nervous system diseases emerged in the late 19th and early 20th centuries, as advances in neurology revealed their profound impact on mortality, disability, and societal burden. Epidemics of encephalitis and poliomyelitis, alongside rising recognition of neurodegenerative disorders, underscored their pervasive reach. Subsequent decades saw international collaboration in research and surveillance, highlighting disparities in diagnosis, treatment, and prevention across regions and populations.

Incidence

Diseases of the central nervous system (CNS) represent a significant global health burden, affecting hundreds of millions of people across all continents. Conditions such as stroke, multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, and various CNS infections contribute to high rates of disability, mortality, and economic loss worldwide. The World Health Organization estimates that neurological disorders account for over 6% of the global disease burden, with incidence rising due to aging populations and improved diagnostic capabilities.
In 2022, Uganda experienced a notable outbreak of cerebral malaria, a severe CNS disease, particularly affecting children under five. Hospitals in Kampala reported increased admissions and fatalities, highlighting the ongoing vulnerability of low-resource regions to CNS infections.

Counter-claim

Claiming that diseases of the central nervous system are not an important problem is misguided. These conditions affect millions, causing immense suffering and disability. To dismiss their significance is to ignore the profound impact on individuals, families, and society. Prioritizing research and treatment is essential for improving quality of life and reducing healthcare burdens. Neglecting this topic would be irresponsible and detrimental to public health.